CHIEFFO, ALAIDE
 Distribuzione geografica
Continente #
AS - Asia 7.277
EU - Europa 6.477
NA - Nord America 4.890
SA - Sud America 1.592
AF - Africa 133
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 20.383
Nazione #
US - Stati Uniti d'America 4.657
RU - Federazione Russa 3.978
SG - Singapore 3.089
CN - Cina 1.964
BR - Brasile 1.315
HK - Hong Kong 964
VN - Vietnam 628
IT - Italia 626
SE - Svezia 418
FR - Francia 374
RO - Romania 281
DE - Germania 202
GB - Regno Unito 138
BD - Bangladesh 130
AR - Argentina 123
IN - India 113
CA - Canada 102
NL - Olanda 78
MX - Messico 77
AT - Austria 71
FI - Finlandia 67
TR - Turchia 63
IQ - Iraq 54
ES - Italia 51
PL - Polonia 51
EC - Ecuador 48
ZA - Sudafrica 43
IE - Irlanda 39
JP - Giappone 38
CO - Colombia 35
ID - Indonesia 34
PK - Pakistan 25
PY - Paraguay 25
SA - Arabia Saudita 22
MA - Marocco 21
UZ - Uzbekistan 19
TN - Tunisia 17
CL - Cile 15
UA - Ucraina 15
CH - Svizzera 14
JM - Giamaica 14
MY - Malesia 14
NP - Nepal 14
VE - Venezuela 14
MD - Moldavia 13
AE - Emirati Arabi Uniti 12
LT - Lituania 12
DZ - Algeria 11
IR - Iran 11
KE - Kenya 11
CR - Costa Rica 10
JO - Giordania 10
PH - Filippine 9
EG - Egitto 8
PE - Perù 8
AU - Australia 7
AZ - Azerbaigian 7
BE - Belgio 7
AL - Albania 6
ET - Etiopia 6
GR - Grecia 6
HN - Honduras 6
HU - Ungheria 5
IL - Israele 5
KR - Corea 5
KW - Kuwait 5
KZ - Kazakistan 5
OM - Oman 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
LB - Libano 4
NG - Nigeria 4
RS - Serbia 4
AO - Angola 3
BH - Bahrain 3
BO - Bolivia 3
CY - Cipro 3
GE - Georgia 3
HR - Croazia 3
PA - Panama 3
PT - Portogallo 3
SC - Seychelles 3
SV - El Salvador 3
TH - Thailandia 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GD - Grenada 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TV - Tuvalu 2
AF - Afghanistan, Repubblica islamica di 1
Totale 20.358
Città #
Singapore 1.429
Dallas 1.124
San Jose 960
Hong Kong 946
Moscow 871
Ashburn 605
Hefei 374
Shanghai 352
Lauterbourg 326
Ho Chi Minh City 241
New York 183
Beijing 171
Lawrence 149
Princeton 149
Milan 145
Hanoi 120
São Paulo 119
Los Angeles 98
Santa Clara 80
Orem 56
Nuremberg 53
Rome 47
Munich 43
Chennai 40
Helsinki 40
Montreal 40
Denver 36
Dublin 36
Amsterdam 35
Shenzhen 35
Warsaw 35
Brooklyn 34
Tokyo 34
Boardman 33
Belo Horizonte 32
Haiphong 30
Mexico City 30
Vienna 29
Brasília 28
Rio de Janeiro 28
Atlanta 27
Chicago 27
Da Nang 27
Guangzhou 27
Phoenix 27
Stockholm 27
London 26
Johannesburg 25
Ankara 23
Baghdad 23
Manchester 23
Buffalo 22
Seattle 22
Council Bluffs 21
Frankfurt am Main 20
Guayaquil 20
Tianjin 20
Salvador 19
Houston 17
Dhaka 16
Poplar 16
Tashkent 16
Toronto 16
Xi'an 16
Boston 15
Guarulhos 15
San Francisco 14
Biên Hòa 13
Goiânia 13
Lappeenranta 13
Manaus 13
Mumbai 13
Porto Alegre 13
Istanbul 12
Turku 12
Asunción 11
Catania 11
Charlotte 11
Hải Dương 11
Quito 11
Thái Bình 11
Assago 10
Bauru 10
Bogotá 10
Campinas 10
Fortaleza 10
Hangzhou 10
Kingston 10
Naples 10
New Delhi 10
Recife 10
Sorocaba 10
St Petersburg 10
Curitiba 9
Falkenstein 9
Jakarta 9
Jeddah 9
Medellín 9
Miami 9
Santiago 9
Totale 10.134
Nome #
European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions 374
Prognostic impact of mitral regurgitation changes after TAVI 225
Aims and Rationale of a National Registry Integrating Clinical, Echocardiographic, and Multi-Omics Profiling to Promote Precision Medicine in Peripartum Cardiomyopathy 191
A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation 168
A Comparison of the Femoral and Radial Crossover Techniques for Vascular Access Management in Transcatheter Aortic Valve Implantation: The Milan Experience 163
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience 149
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 141
A comparison Of The Femoral And Radial Crossover Techniques For Vascular Access Management In Transcatheter Aortic Valve Implantation: The Milan Experience 139
A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience 127
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 126
Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience 125
A challenging case of transcatheter aortic prosthesis dysfunction: Endocarditis or thrombosis? 119
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) 118
Coronary Protection to Prevent Coronary Obstruction During TAVR 117
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease 110
A Sex-Based Analysis From the RAIN-CARDIOGROUP VII Study (VeRy Thin Stents for Patients With Left MAIn or BifurcatioN in Real Life) on Left Main Stenting 109
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 109
A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure 107
Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations 106
Valve-in-valve transcatheter aortic valve implantation: The issues behind crossing a bioprosthesis 104
A complex valve anatomy for mitraclip: Forme fruste of Barlow’s disease with cleft 103
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 103
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 102
"Procedural trauma risks longitudinal shortening of the Promus Element™ stent platform" 100
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 99
Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization 98
Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: The IMP-IT Registry 98
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 95
Impact of Ascending Aorta Dilation on Mid-Term Outcome After Transcatheter Aortic Valve Implantation 95
A New Tool to Manage Side-Branch Occlusion After Covered-Stent Implantation for Vascular Complications The Neocarina Reconstruction Technique 95
Device-related complications after Impella mechanical circulatory support implantation: An IMP-IT observational multicentre registry substudy 94
Repeated Transcatheter Valve Interventions After Surgical Mitral Valve Replacement: A 20-Year Journey Avoiding Surgical Redo 91
A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane 90
Challenges and Opportunities for Women in Vascular Surgery: Summary from an International Roundtable Discussion 87
Real-Time Intravascular Ultrasound Guidance for Ultra-Low Contrast Complex Bifurcation Percutaneous Coronary Intervention 86
A novel approach to chronic total occlusions: the crosser system 86
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 84
Sex-Specific Considerations in Degenerative Aortic Stenosis for Female-Tailored Transfemoral Aortic Valve Implantation Management 83
A High Dose of Adenosine to Induce Transient Asystole for Valvuloplasty in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): Is it a Valid Alternative to Rapid Pacing? A Prospective Pilot Study 83
Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes 82
Percutaneous coronary intervention for unprotected left main distal bifurcation lesions in elderly people 81
Coronary Artery Aneurysm Thrombosis Causing Acute Myocardial Infarction in an Adolescent With Neurofibromatosis Type 1 80
Active Protection of High-Risk Small Side Branches in Bifurcation Interventions Is Preventing Occlusion Always Clinically Relevant? 79
Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions 79
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 77
Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry 77
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions 75
Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry 75
Impact of Kissing Balloon in Patients Treated With Ultrathin Stents for Left Main Lesions and Bifurcations An Analysis From the RAIN-CARDIOGROUP VII Study 74
Ultrasound-Assisted, Catheter-Directed Thrombolysis for Acute Intermediate/High-Risk Pulmonary Embolism: Design of the Multicenter USAT IH-PE Registry and Preliminary Results 73
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 72
Can a mechanical circulatory support comprehensive approach to cardiogenic shock at referral centers reduce 30-day mortality? 72
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 71
Rotational atherectomy-based percutaneous coronary intervention and the risk of contrast-induced nephropathy 71
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents 70
Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: the LIRA method 70
Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside 70
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 69
Percutaneous treatment of acute pulmonary embolism: state of the art 68
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries 68
Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve 68
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents 68
Discrepancies in vessel sizing between angiography and intravascular ultrasound varies according to the vessel evaluated 67
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 67
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 67
Gender-Related Differences in Clinical Presentation and Angiographic Findings in Patients with Ischemia and No Obstructive Coronary Artery Disease (INOCA): A Single-Center Observational Registry 67
First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome 66
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 66
Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement 66
Coronary Vasomotor Disorders: One Size Does Not Fit All 65
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis SCOPE 2 Randomized Clinical Trial 65
Impact of Post-Percutaneous Coronary Intervention Fractional Flow Reserve Measurement on Procedural Management and Clinical Outcomes: The REPEAT-FFR Study 65
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week 65
Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes 65
Interatrial Septal Tear After Patent Foramen Ovale Closure With the NobleStitch Device 65
Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study) 65
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group 64
Vascular Access Management for Transcatheter Aortic Valve Implantation - Procedural Results from the Crossover Balloon Technique 64
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 64
Comparison of Incidence and Predictors of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Using the CoreValve Versus the Edwards Valve 64
Transcatheter aortic bioprosthesis durability: A single center experience 63
Aspirin intolerance and the need for dual antiplatelet therapy after stent implantation: a proposed alternative regimen 63
Correction: Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry (vol 14, pg 198, 2021) 62
The feasibility of double stent strategy in left main true bifurcation with small and large angle change between diastole and systole: The Milan and New-Tokyo (MITO) registry 62
Impact of Mean Platelet Volume on Combined Safety Endpoint and Vascular and Bleeding Complications following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation 61
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 61
The development of a Hub & Spoke network for transcatheter aortic valve replacement procedures: the operational model of the Interventional Cardiology Unit at the IRCCS San Raffaele Hospital (OSR Hub-Spoke) 61
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases ofCOVID-19 60
Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices 60
Sex Differences in Use of Intracoronary Imaging in Patients Undergoing Percutaneous Coronary Intervention 60
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 60
Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents 59
Mortality across treatment strategies in intermediate-to-high risk pulmonary embolism in the modern era: A meta-analysis of observational studies and RCTs 59
Two-year outcomes following unprotected left main stenting with first vs. new-generation drug-eluting stents: the FINE registry 59
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 58
Evolution, Predictors, and Neurocognitive Effects of Silent Cerebral Embolism During Transcatheter Aortic Valve Replacement 58
Impact of Chronic Kidney Disease in Patients With Diabetes Mellitus after Percutaneous Coronary Intervention for Left Main Distal Bifurcation (From the Milan and New-Tokyo (MITO) Registry) 58
Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry 58
Early and mid-term results of drug-eluting stent implantation in unprotected left main 58
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 58
Totale 8.763
Categoria #
all - tutte 122.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202279 0 0 0 40 4 2 6 7 5 0 4 11
2022/2023964 328 170 45 5 2 83 35 46 18 10 14 208
2023/2024670 124 41 84 38 53 86 6 49 16 15 47 111
2024/20254.728 507 73 73 83 113 381 964 299 754 699 399 383
2025/202614.481 1.054 1.259 1.306 1.814 1.011 454 1.665 916 3.659 897 437 9
Totale 21.009